by 30 Technology | Oct 22, 2020 | News
30 Technology announces first patients enrolled in UK clinical trial (NOCoV2) for the treatment of COVID-19 London, UK, 22 October 2020. Thirty Respiratory Ltd (“30 Technology”) announced today that the first patients have been enrolled in the multicentre Phase 2/3...
by 30 Technology | Jun 18, 2020 | News
Thirty Respiratory gets Regulatory Approval to start international, open-label, randomised, multi-centre Phase 2/3 trial of RESP301 in patients hospitalised with COVID-19 London, UK, 18 June 2020. Thirty Respiratory Limited* a world-leader in Nitric Oxide medical...
Recent Comments